Skip to main content
Premium Trial:

Request an Annual Quote

University of Edinburgh Spinout Raises £8.5M to Commercialize Long-Read RNA-seq Technology

NEW YORK – University of Edinburgh spinout Wobble Genomics said Thursday that it has raised £8.5 million ($10.8 million) in venture capital to help commercialize its sequencing-based full-length RNA detection technology.

The funding round, which brings the total amount raised by the company to over £10.5 million, was led by Mercia Ventures and BGF, with additional contributions from IQ Capital, EOS Advisors, and Old College Capital, the University of Edinburgh’s venture fund.

Wobble, which is still operating in stealth mode, has developed a method that enables the optimal detection of full-length RNA using long-read sequencing. The company believes its technology could have "wide-ranging applications," including in drug development, basic research, agriculture, and ecology.

According to the company’s website, it has developed a cDNA library normalization technology called Level-Up that does not use targeted probes or depletion and creates a uniform distribution of all unique sequences.

Additionally, the firm has developed a software package called Tama for analyzing long-read RNA sequencing data.

Established in 2021 by Richard Kuo, a researcher at the University of Edinburgh’s Roslin Institute, Wobble currently has 10 employees. The firm noted that it expects to double in size in the next two years.